Strongbridge Biopharma (SBBP) Short Interest Ratio & Short Volume → the most reliable asset on earth is making a comeback (From DTI) (Ad) Free SBBP Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Short InterestStock Analysis Strongbridge Biopharma Short Interest DataCurrent Short Volume454,600 sharesPrevious Short Volume528,000 sharesChange Vs. Previous Month-13.90%Dollar Volume Sold Short$959,206.00Short Interest Ratio / Days to Cover1.0Last Record DateSeptember 15, 2021Outstanding Shares67,829,000 sharesFloat Size49,030,000 sharesShort Percent of Float0.93%Today's Trading Volume684,684 sharesAverage Trading Volume866,464 sharesToday's Volume Vs. Average79% Short Selling Strongbridge Biopharma ? Sign up to receive the latest short interest report for Strongbridge Biopharma and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatSBBP Short Interest Over TimeSBBP Days to Cover Over TimeSBBP Percentage of Float Shorted Over Time Ad DTICBOE shift unlocks new weekend income strategyYou might not immediately realize what you’re reading. Let me help you out a little… What you're looking at is a “special perk” set up by the Chicago Board of Options Exchange. You're probably wondering, “Okay… But how does that affect me?” This perk now allows everyday traders like yourself to target extra income over the weekend. Check out this training for the full story! Strongbridge Biopharma Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 9/15/2021454,600 shares $959,206.00 -13.9%0.9%1 $2.11 8/31/2021528,000 shares $1.19 million +4.6%1.1%1 $2.25 8/13/2021504,800 shares $979,312.00 -11.6%1.0%0.5 $1.94 7/30/2021570,800 shares $1.36 million +6.6%1.2%0.5 $2.39 7/15/2021535,500 shares $1.41 million -37.3%1.0%0.5 $2.64 6/30/2021854,500 shares $2.54 million -54.3%1.7%0.7 $2.97 Get the Latest News and Ratings for SBBP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Strongbridge Biopharma and its competitors with MarketBeat's FREE daily newsletter. 6/15/20211,870,000 shares $5.42 million -0.5%3.6%1.6 $2.90 5/28/20211,880,000 shares $4.74 million +19.8%3.6%1.4 $2.52 5/14/20211,570,000 shares $3.61 million -4.3%3.0%1.2 $2.30 4/30/20211,640,000 shares $4.35 million +13.9%3.2%1.5 $2.65 4/15/20211,440,000 shares $3.59 million +42.6%2.7%1.3 $2.49 3/31/20211,010,000 shares $2.75 million +47.2%1.9%0.9 $2.72 3/15/2021686,200 shares $2.04 million +15.6%1.3%0.7 $2.98 2/26/2021593,400 shares $1.90 million -14.6%1.1%0.8 $3.21 2/12/2021694,500 shares $2.35 million +5.6%1.3%1.1 $3.38 1/29/2021657,500 shares $1.79 million -0.7%1.2%1.4 $2.73 1/15/2021662,300 shares $1.95 million -6.1%1.3%1.4 $2.94 12/31/2020705,000 shares $1.78 million +15.8%1.3%1.5 $2.52 12/15/2020608,800 shares $1.69 million -21.3%N/A1.4 $2.77 11/30/2020773,600 shares $2.14 million +9.3%1.4%1.3 $2.76 11/15/2020707,500 shares $1.80 million -11.7%1.3%1.2 $2.55 10/30/2020801,100 shares $1.51 million +0.9%1.5%1.4 $1.89 10/15/2020793,700 shares $1.73 million -9.2%1.8%1.4 $2.18 9/30/2020873,600 shares $1.83 million +1.3%2.0%1.5 $2.10 9/15/2020862,800 shares $2.44 million +4.4%2.1%1.6 $2.83 8/31/2020826,300 shares $3.17 million +13.0%2.0%1.9 $3.84 8/14/2020731,200 shares $2.70 million -0.8%1.8%1.8 $3.69 7/31/2020737,400 shares $2.49 million +24.5%1.8%2 $3.37 7/15/2020592,400 shares $2.01 million -13.4%1.4%1.7 $3.40 6/30/2020684,000 shares $2.59 million +83.9%1.9%1.9 $3.78 6/15/2020371,900 shares $1.32 million -4.1%1.1%1.1 $3.54 5/29/2020387,800 shares $1.33 million -21.6%1.1%1.2 $3.42 5/15/2020494,700 shares $1.44 million +0.1%1.4%1.3 $2.91 4/30/2020494,300 shares $1.41 million -2.4%1.0%1.5 $2.86 4/15/2020506,300 shares $1.06 million +3.5%1.0%1.3 $2.09 3/31/2020489,400 shares $1.11 million +0.8%1.4%1.1 $2.26 3/13/2020485,500 shares $932,160.00 +39.9%1.4%1.2 $1.92 2/28/2020347,000 shares $586,430.00 -5.9%1.0%0.7 $1.69 2/14/2020368,700 shares $914,376.00 +1.8%1.1%0.8 $2.48 1/31/2020362,300 shares $952,849.00 -8.0%1.1%0.8 $2.63Crypto Market Preps For Trillions Worth of Inflows! (Ad)Bitcoin is rapidly approaching new ALL-TIME HIGHS… The market is buzzing after recent approval of spot Bitcoin exchange-traded funds (ETF). Top analysts predict these ETFs will attract trillions of dollars worth of inflows over the next few years… And as Bitcoin rallies, we could see other smaller coins rise to heights never seen before.Click to join the Crypto Community Summit Free Online Event SBBP Short Interest - Frequently Asked Questions What is Strongbridge Biopharma's current short interest? Short interest is the volume of Strongbridge Biopharma shares that have been sold short but have not yet been covered or closed out. As of September 15th, investors have sold 454,600 shares of SBBP short. 0.93% of Strongbridge Biopharma's shares are currently sold short. Learn More on Strongbridge Biopharma's current short interest. What is a good short interest ratio for Strongbridge Biopharma? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. SBBP shares currently have a short interest ratio of 1.0. Learn More on Strongbridge Biopharma's short interest ratio. What is a good short interest percentage for Strongbridge Biopharma? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.93% of Strongbridge Biopharma's floating shares are currently sold short. Is Strongbridge Biopharma's short interest increasing or decreasing? Strongbridge Biopharma saw a drop in short interest in September. As of September 15th, there was short interest totaling 454,600 shares, a drop of 13.9% from the previous total of 528,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Strongbridge Biopharma's float size? Strongbridge Biopharma currently has issued a total of 67,829,000 shares. Some of Strongbridge Biopharma's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Strongbridge Biopharma currently has a public float of 49,030,000 shares. How does Strongbridge Biopharma's short interest compare to its competitors? 0.93% of Strongbridge Biopharma's shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Strongbridge Biopharma: PDS Biotechnology Co. (17.71%), Syros Pharmaceuticals, Inc. (9.57%), Acrivon Therapeutics, Inc. (4.04%), BeyondSpring Inc. (9.90%), Relmada Therapeutics, Inc. (5.80%), NGM Biopharmaceuticals, Inc. (3.20%), CytomX Therapeutics, Inc. (5.21%), Emergent BioSolutions Inc. (9.81%), Citius Pharmaceuticals, Inc. (7.66%), Annovis Bio, Inc. (17.31%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Block, Inc. ($9.12 billion), S&P Global Inc. ($7.79 billion), Advanced Micro Devices, Inc. ($6.62 billion), Charter Communications, Inc. ($6.07 billion), Wayfair Inc. ($4.53 billion), Zoom Video Communications, Inc. ($3.45 billion), Uber Technologies, Inc. ($3.08 billion), Canadian Pacific Kansas City Limited ($2.97 billion), Palo Alto Networks, Inc. ($2.74 billion), and MongoDB, Inc. ($2.61 billion). View all of the most shorted stocks. What does it mean to sell short Strongbridge Biopharma stock? Short selling SBBP is an investing strategy that aims to generate trading profit from Strongbridge Biopharma as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Strongbridge Biopharma? A short squeeze for Strongbridge Biopharma occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of SBBP, which in turn drives the price of the stock up even further. How often is Strongbridge Biopharma's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including SBBP, twice per month. The most recent reporting period available is September, 15 2021. More Short Interest Resources from MarketBeat Related Companies: PDS Biotechnology Short Interest Syros Pharmaceuticals Short Interest Acrivon Therapeutics Short Interest BeyondSpring Short Interest Relmada Therapeutics Short Interest NGM Biopharmaceuticals Short Interest CytomX Therapeutics Short Interest Emergent BioSolutions Short Interest Citius Pharmaceuticals Short Interest Annovis Bio Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:SBBP) was last updated on 3/28/2024 by MarketBeat.com Staff From Our PartnersTop Project Outperforms BTC in 2023…Crypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyBREAKING: New AI Breakthrough Could Change Healthcare ForeverBehind the Markets“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisorySHOCKING Footage From Tesla Gigafactory In Austin, TexasInvestorPlaceBuy this small stock before coming AI Tidal WaveChaikin AnalyticsThe 3rd Revolution in WarfareWeiss Ratings